Đang chuẩn bị liên kết để tải về tài liệu:
Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Breast cancer is the most common invasive cancer among women. Currently, there are only a few models used for therapy selection, and they are often poor predictors of therapeutic response or take months to set up and assay. | Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform

TÀI LIỆU LIÊN QUAN

Concurrent clinical and pathological response predicts favorable prognosis of patients with gastric cancer after neoadjuvant therapy: A real-world study

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda

PDXGEM: Patient-derived tumor xenograftbased gene expression model for predicting clinical response to anticancer therapy in cancer patients

Intraoperative radiation therapy induces immune response activity after pancreatic surgery

Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data

Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): Study protocol of a multicentre randomized controlled trial

Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer

The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer

Ebook Animal assisted therapy in counseling: Part 2

An agent-based model of prostate Cancer bone metastasis progression and response to Radium223